Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 70 years old (any gender) who are able to drink liquids
- People who have been diagnosed with esophageal squamous cell carcinoma (a specific type of oesophageal cancer) confirmed by a tissue test
- People whose cancer has been assessed as not suitable for surgery, or who have chosen not to have surgery
- People whose cancer falls within a specific staging range according to the 2017 AJCC oesophageal cancer staging system (from T2N0M0 up to TxNxM0) (confirm with trial site)
- People with a general health score of 0 or 1 on the ECOG scale, meaning they are either fully active or have mild limitations, and a life expectancy of more than 6 months
- People who have not previously had chemotherapy
- People who have not previously had radiotherapy
- People who have not had surgical treatment for their cancer
- People with no history of serious allergic reactions
- People whose blood count and organ function results fall within specific acceptable ranges, including adequate levels of haemoglobin, white blood cells, neutrophils, and platelets, and normal-range liver and kidney function results (confirm with trial site)
- People who are able to understand the study and have signed a consent form
Who may not be able to join:
- People who have had, or currently have, a cancer in another part of the body
- People with more than one separate cancer occurring in the oesophagus at the same time
- People who are pregnant or breastfeeding
- People who are able to have children but are not using contraception
- People with serious ongoing health conditions, including very high-risk high blood pressure, severe lung problems, a recent major heart attack, significant heart failure (Grade II or above), a history of mental illness, or severe diabetes
- People currently experiencing an active infectious disease
- People currently participating in, or who have participated in, another clinical trial within the four weeks before joining
- People currently receiving other cancer treatments, including anti-cancer traditional Chinese medicine
- People who have had an oesophageal stent placed
- People whose cancer shows signs that it may be at risk of causing a perforation (a tear or hole in the oesophagus)
- People who have had an organ transplant
- People whose cancer has spread widely to other parts of the body, such as the lungs, liver, bones, or brain
- People known or suspected to be allergic to chemotherapy drugs
- People who, in the treating doctor's judgement, have other conditions that could seriously affect their safety or their ability to complete the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaolin GE, MM, The First Affiliated Hospital with Nanjing Medical University
Phone: 13951818797
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-years overall survival (OS); 5-years overall survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.